Eli Lilly and Company
THERAPY FOR METATASTIC COLORECTAL CANCER USING ANTI-VEGFR-2 and ANTI-VEGF-D ANTIBODIES
Last updated:
Abstract:
The invention provides for methods, treatments, and uses for anti-human VEGFR-2 antibodies for the treatment of metastatic colorectal cancer in patients having elevated levels of VEGF-D.
Status:
Application
Type:
Utility
Filling date:
10 Nov 2017
Issue date:
27 Feb 2020